I continued working at the interface of science and epidemiology, first with Genaissance Pharmaceuticals, a New Haven - based
pharmacogenomics company, where I was
involved in the fascinating study of human genetic variation and population genetics.
Clinical and Regenerative medicine refers to development and implementation of advanced therapeutic approaches that may
involve the support of expertise in gene / cell therapy, tissue engineering, pharmacology and
pharmacogenomics, development of novel molecular target therapy.